Methylprednisolone pulse therapy for severe immune thrombocytopenia associated with infectious mononucleosis.
Takahashi
Tohru
T
Hamasaka
Nanaka
N
Harada
Sayaka
S
Sugawara
Nobuaki
N
Yoshimoto
Mitsuru
M
D000284:Administration, Oral; D000293:Adolescent; D004334:Drug Administration Schedule; D004844:Epistaxis / Q000209:etiology / Q000628:therapy; D005260:Female; D006417:Hematuria / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D007244:Infectious Mononucleosis / Q000097:blood / Q000150:complications*; D007262:Infusions, Intravenous; D008775:Methylprednisolone / Q000008:administration & dosage* / Q000627:therapeutic use; D053657:Platelet-Rich Plasma; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D020551:Pulse Therapy, Drug; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy* / Q000209:etiology
D007166:Immunosuppressive Agents; D011239:Prednisolone; D008775:Methylprednisolone